CARBIDOPA AND LEVODOPA

Pre-Launch

carbidopa,levodopa

Biocon
ANDACAPSULE, EXTENDED RELEASE
Lifecycle
Pre-Launch
Clinical Trials
1

Mechanism of Action

Mechanism of Action Parkinson's disease is a progressive, neurodegenerative disorder of the extrapyramidal nervous system affecting the mobility and control of the skeletal muscular system. Its characteristic features include resting tremor, rigidity, and bradykinetic movements. Symptomatic…

Indications (8)

the treatment of Parkinson's diseasepost-encephalitic parkinsonismsymptomatic parkinsonismmanganese intoxicationParkinson's diseasenauseavomitingpermit more rapid titration of levodopa

Clinical Trials (1)

NCT01533116Phase 1Completed

Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide

Started Mar 2009
Company
B
Biocon
India - Bangalore
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers